Trial intelligence / Profile preview

LDFRT with Induction Chemo in Nasopharyngeal Cancer

NCT03890185Phase 2Unknown

Sponsor
King Faisal Specialist Hospital and Research Centre
Start
Oct 2012
Primary completion
Dec 2020
01

Overview

Phase 2, randomised, open-label trial in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: Evaluation of chemo and radiation toxicities at 3 years. Status: unknown.

02

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT03890185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03890185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call